Trial reportBMC nephrology2026
The Physical ACtivity Enhancement Scheme (PACES) improves physical activity level and well-being in persons with hemodialysis: a randomized controlled trial.
Trial report in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05718765 (The Effect of Physical ACtivity Enhancement Scheme), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effect of Physical ACtivity Enhancement Scheme (PACES) on Physical Outcomes in Hemodialysis Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo evaluate the effects of the Physical ACtivity Enhancement Scheme (PACES) on the physical activity levels and well-being of hemodialysis patients.
methodsThis is a single-blinded, two-arm, parallel-group, randomized controlled trial. Participants were recruited in September 2022 and randomly allocated to the intervention and control groups at a 1:1 ratio. The intervention group received a 3-month PACES intervention in addition to routine care, while the control group received only routine care. Baseline and post-intervention data were collected via electronic medical records and questionnaires. Daily step count was defined as the primary outcome, and other relevant indicators were set as secondary outcomes.
resultsA total of fifty-three participants completed the study. Regarding the primary outcome, the intervention group obtained significant improvements in daily step count compared with the control group after intervention. In terms of secondary outcomes, the intervention group also showed clear advantages in perceptions of exercise benefits and barriers, exercise self-efficacy, utilization of social support, the effect of kidney disease, the burden of kidney disease, the physical component summary, and the mental component summary.
conclusionsThese findings suggest that the PACES intervention may improve physical activity level and other health-related outcomes among hemodialysis patients. Given the limitations of single-centre design and relatively small sample size, further multi-centre and large-scale studies are warranted to examine its potential generalizability. This intervention has potential clinical value for helping patients maintain health and improve overall well-being during dialysis treatment.
trial registrationClinicalTrials.gov Identifier NCT05718765. Registered on 24 December 2022. Retrospectively registered.
Indexed as
Identifiers
42855667What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.